Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add filters








Language
Year range
1.
Neurol India ; 2000 Jun; 48(2): 187-8
Article in English | IMSEAR | ID: sea-121443

ABSTRACT

Neurological manifestations of skeletal fluorosis have been attributed to compressive radiculomyelopathy. Experimental fluorosis has shown evidence of myopathic changes. Data on human muscle pathology is very scanty. This study included 22 patients with established osteofluorosis. 16 of them showed only EMG changes of neurogenic muscle disease. Histochemistry and histopathology of muscle biopsies showed features of muscle atrophy, evidenced by 'type I' atrophy and 'type I' grouping. No myopathic changes were observed. It may be concluded that the primary changes are related to the nerve, with muscle being affected secondarily. There was no evidence of any primary muscle pathology due to fluorosis.


Subject(s)
Adenosine Triphosphatases/metabolism , Adult , Aged , Bone Diseases/chemically induced , Endemic Diseases , Female , Fluoride Poisoning/epidemiology , Humans , Male , Middle Aged , Muscle, Skeletal/pathology
2.
Indian J Exp Biol ; 1989 May; 27(5): 442-4
Article in English | IMSEAR | ID: sea-57792

ABSTRACT

Bleomycin (Blm) induced break points in human chromosome preparations were compared with the known fragile sites. A total of 136 breaks were observed from 100 well spread G-banded plates (1.3 bps/cell). These correspond to a total of 57 break prone sites. Of these 57 sites, 24 correspond to the known fragile sites, 5 to sites of protooncogenes and neoplasia, 26 sites correspond to more than one known site of fragility, protooncogene, neoplasia or reciprocal translocation sites, and 2 unknown sites. The findings suggest that fragile sites, either commonly expressed or induced, might be a predisposing factor for chromosome aberrations in human. The expression of fragile sites induced by Blm and their correlation with the known cancer chromosome break points, oncogenes and reciprocal translocation, suggest that the fragile sites are prone to mutagenic action.


Subject(s)
Bleomycin/pharmacology , Chromosome Fragile Sites , Chromosome Fragility , Chromosomes, Human/drug effects , Humans , Karyotyping
SELECTION OF CITATIONS
SEARCH DETAIL